1. Robust association of the APOEℇ4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: the Aachen study.
- Author
-
Schmitz, F., Mevissen, V., Krantz, C., Kimmel, M., Erdmann, J., Hoffmann, R., Zerres, K., and Ortlepp, J. R.
- Subjects
CORONARY disease ,MYOCARDIAL infarction ,HYPERCHOLESTEREMIA ,HEART diseases ,APOLIPOPROTEIN E - Abstract
Background Genetic influence on the manifestation of coronary artery disease (CAD) and myocardial infarction (MI) has been shown previously. From many candidate genes the APOE (apolipoprotein E) with the major alleles ℇ2/ℇ3/ℇ4 is in the focus of interest. Materials and methods In 1817 patients admitted for their first left heart catheterization at a premature age (males < 55 and females < 65) the association of APOE alleles with MI was analysed. Genotyping was done by 5′ exonuclease assay (TaqMan
(M) ). Results APOE was significantly associated with hypercholesterolaemia (ℇ4 72% vs. ℇ3 66% vs. ℇ2 51%; P < 0·0001), and premature MI (ℇ4 57% vs. ℇ3 50% vs. ℇ2 41%; P < 0·0001; hazard ratio 1·41, 95%CI 1·14–1·75). In patients without hypercholesterolaemia, the APOE allele ℇ4 was highly predictive for the presence of premature MI (ℇ4 55% vs. ℇ3 45% vs. ℇ2 28%; P < 0·0001; hazard ratio 1·75, 95%CI 1·19–2·57). Conclusion The APOEℇ4 allele shows a robust association with premature MI independent of hypercholesterolaemia. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF